Tirzepatide

Cosa succede davvero quando si sospendono i farmaci per dimagrire? – Mondosanità

by

When patients stop taking modern anti-obesity medications, the physiological changes often reverse rapidly, raising critical questions about long-term management for chronic conditions. Recent clinical insights from medical journals and healthcare reporting highlight that discontinuing treatments such as GLP-1 receptor agonists frequently leads to significant weight regain and shifts in body composition. According to data and … Read more

Ještě účinější než Ozempic. Zázračný lék nové generace je průlomový, funguje odlišně – E15.cz

by

The landscape of weight-loss pharmacology is shifting rapidly as pharmaceutical companies push the boundaries of metabolic medicine. Recent clinical data regarding the experimental drug retatrutide have captured the attention of the medical community, suggesting a potential step forward in the treatment of obesity. As researchers continue to evaluate the efficacy and safety of this new … Read more

GLP-1 and Obesity Treatment: Metabolic Health, Long-Term Therapy, and Future Innovations

by

For decades, the global approach to treating obesity was framed primarily as a battle of willpower. Patients were told to “eat less and move more,” a mantra that often ignored the complex biological drivers of weight gain and the stubborn nature of metabolic adaptation. However, a pharmacological shift is currently underway, transforming obesity from a … Read more